EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Analyzing Pharmacodynamic Count Data That Rapidly Decrease to Zero

Walter M Yamada iD, Alan Schumitzky, Alona Kryshchenko iD, Julian Otalvaro iD, Sarah Kim iD, Arnold Louie iD, George Drusano iD, Michael N Neely iD

CPT: Pharmacometrics & Systems Pharmacology · 2026

DOI: 10.1002/psp4.70140 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, 2026. Verfasst von Walter M Yamada und 7 weiteren Autor:innen. Beteiligte Einrichtung: Children's Hospital Los Angeles, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Models, Biological. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We present a framework for maximum likelihood analysis on count observations that begin high and quickly drop to zero, for example, from hollow fiber drug comparison studies. This simulation study focuses on treating observed counts as Poisson or normally distributed for the purpose of estimating infection rebound after effective treatment. CFU profiles were simulated from inoculation to 96 h post‐treatment. The PK‐PD link was an Emax inhibitory model. Random parameters were pathogen growth and natural decay rates, drug concentration for half‐maximal effect, and drug pathogen kill rate. Other parameters, including PK, were fixed. Parameters were adjusted to attain 67% efficacy at 24 h. Random parameter values were optimized for profiles observed at 24, 48, 72, and 96 h assuming each of four probability assumptions: (1) all CFU measurements were Poisson distributed (truth); (2) CFU < 128 were Poisson, higher values were normally distributed; (3) all observations were normally distributed; and (4) observations were normally distributed but CFU < 10 were censored. CFU‐time profiles were re‐simulated using the optimized parameter densities. Rebound percentage (CFU ≥ 10 at 24 h post‐treatment) was best predicted using strategy 2, above. For limited periodically collected time series count data that quickly fall to 0, the true proportion reaching 0 (lack of rebound) was best modeled by assuming Poisson distribution at low counts. At higher counts (≥ 128), assuming normality is reasonable. Censoring observations leads to biased models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Models, BiologicalComputer SimulationPoisson DistributionHumansLikelihood FunctionsColony Count, Microbial

Stichwörter der Autor:innen

PmetricsPoisson distributioncolony‐forming unitcount datanonparametric maximum likelihood

Autor:innen und Institutionen

  • Children's Hospital Los Angeles, Los Angeles, California, USA.
  • California State University Channel Islands, Camarillo, California, USA.
  • Institute for Therapeutic Innovation, University of Florida, Orlando, Florida, USA.

ORCID-Profile: Walter M Yamada, Alona Kryshchenko, Julian Otalvaro, Sarah Kim, Arnold Louie, George Drusano, Michael N Neely

Zitieren

APA

Yamada, W. M., Schumitzky, A., Kryshchenko, A., Otalvaro, J., Kim, S., Louie, A., Drusano, G., & Neely, M. N. (2026). Analyzing Pharmacodynamic Count Data That Rapidly Decrease to Zero. CPT: Pharmacometrics & Systems Pharmacology. https://doi.org/10.1002/psp4.70140

Vancouver

Yamada WM, Schumitzky A, Kryshchenko A, Otalvaro J, Kim S, Louie A, et al. Analyzing Pharmacodynamic Count Data That Rapidly Decrease to Zero. CPT: Pharmacometrics & Systems Pharmacology. 2026. doi:10.1002/psp4.70140

BibTeX
@article{Yamada2026,
  author = {Yamada, Walter M and Schumitzky, Alan and Kryshchenko, Alona and Otalvaro, Julian and Kim, Sarah and Louie, Arnold and Drusano, George and Neely, Michael N},
  title = {Analyzing Pharmacodynamic Count Data That Rapidly Decrease to Zero},
  journal = {CPT: Pharmacometrics & Systems Pharmacology},
  year = {2026},
  doi = {10.1002/psp4.70140}
}
Kostenlos starten →